By the 12 months post-CNS diagnosis the mean number of albumin infusions significantly decreased from 14.8 ± 8.7 to 9.1 ± 6.5 days/month, with values fluctuating at lower levels (from an IQR of 8–24 to IQR 3–15), whereas the median remained at 12 days/month (p = 0.007); however, the median number of infections (2 [IQR: 1–3.5], p = 0.589), hospitalizations (5 [IQR: [2–14], p = 0.5), and median hospitalization duration (days) (8 [IQR: 4–27.5]; p = 0.218), did not differ significantly from baseline. This evidence concerns the gene ALB and infection.